Sarah Cannon Research Institute
Nashville, Tennessee
Dr. Hamilton received her undergraduate degree from Washington and Lee University in Virginia and received a NCAA Postgraduate Scholarship. She then completed her medical degree and residency from University of North Carolina in Chapel Hill and fellowship training in oncology at Duke University. She joined Sarah Cannon Research Institute as investigator in drug development for women’s cancers in 2013. Since 2015 she has served as the Director of the Breast and Gynecologic Cancer Research Program. She sees patients facing breast and gynecologic cancers from standard of care to phase II/III to phase I drug development.
Dr. Hamilton is the past Chair of ASCO’s Scientific Committee for Metastatic Breast Cancer for 2019-2020. She serves on the Board of Directors for Susan G Komen middle Tennessee for 3 years running and is an Associate Editor for Clinical Breast Cancer. She was named to the Women to Watch Class of 2021 for Nashville Medical News. She is also in ASCO’s current Leadership Development Class for 2021-2022.
ArQule, Clovis, Silverback Therapeutics, Millenium, Acerta Pharma, Sermonix Pharmaceuticals, Torque (Individual(s) Involved: Self): Grant/Research Support; AstraZeneca, Arvinas, Deciphera Pharmaceuticals, Eisai, Seagen (Individual(s) Involved: Self; Clinical Condition: No Personal Fees): Consultant; Black Diamond, Karyopharm, Infinity Pharmaceuticals, Curis, Syndax, Novartis, Boehringer Ingelheim, (Individual(s) Involved: Self): Grant/Research Support; Compugen, TapImmune, Lilly, Pfizer, H3 Biomedicine, Takeda, Merus, Regeneron, Arvinas, StemCentRx (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; Dana Farber Cancer Hospital, Hutchinson MediPharma, MedImmune, SeaGen, Puma Biotechnology (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; EMD Serono, Daiichi Sankyo, Syros, Sutro, G1 Therapeutics, Merck, PharmaMar, Olema, Polyphor (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; Genentech/ Roche (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; Genentech/Roche, Boehringer Ingelheim, Novartis, Dantari, Lilly, Merck, Puma Biotechnology (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Consultant, no personal fees; Immunogen, Plexxicon, Amgen, Akesobio Australia, Shattuck Labs (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; Immunomedics, FujiFilm, Taiho, Deciphera, Fochon, Molecular Templates, Onconova Therapeutics (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; Nucana, Leap Therapeutics, Zenith Epigenetics, Harpoon, Orinove, AstraZeneca, Tesaro, Macrogenics (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; OncoMed (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; Rgenix (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): all payable to institution, Grant/Research Support; Silverback Therapeutics, CytomX, Pfizer, Mersana, Black Diamond, H3 Biomedicine, Daiichi Sankyo (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Consultant, no personal fees; Verastem, eFFECTOR Therapeutics, CytomX, InventisBio, Lycera, Mersana, Radius Health, Abbvie (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support; ZYMEWORKS (Individual(s) Involved: Self; Clinical Condition: No Personal Fees - all to institution): Grant/Research Support
Wednesday, April 27, 2022
9:00 AM – 10:15 AM
Wednesday, April 27, 2022
9:00 AM – 9:05 AM
Wednesday, April 27, 2022
9:05 AM – 9:25 AM
Wednesday, April 27, 2022
10:00 AM – 10:15 AM
Wednesday, April 27, 2022
11:35 AM – 1:15 PM
Wednesday, April 27, 2022
11:35 AM – 11:40 AM
Wednesday, April 27, 2022
12:50 PM – 1:15 PM
Thursday, April 28, 2022
9:00 AM – 10:10 AM
Thursday, April 28, 2022
9:00 AM – 9:05 AM
Thursday, April 28, 2022
9:45 AM – 10:10 AM
Thursday, April 28, 2022
11:30 AM – 12:20 PM
Thursday, April 28, 2022
11:30 AM – 11:35 AM
Thursday, April 28, 2022
11:35 AM – 11:50 AM
Thursday, April 28, 2022
12:05 PM – 12:20 PM
Thursday, April 28, 2022
12:30 PM – 1:35 PM
Thursday, April 28, 2022
12:30 PM – 12:35 PM
Thursday, April 28, 2022
1:15 PM – 1:35 PM
Thursday, April 28, 2022
1:55 PM – 3:30 PM
Thursday, April 28, 2022
1:55 PM – 2:00 PM
Thursday, April 28, 2022
3:00 PM – 3:30 PM
Wednesday, September 21, 2022
9:10 AM – 10:15 AM
Wednesday, September 21, 2022
9:10 AM – 9:15 AM
Wednesday, September 21, 2022
9:55 AM – 10:15 AM
Wednesday, September 21, 2022
11:35 AM – 1:15 PM
Wednesday, September 21, 2022
11:35 AM – 11:40 AM
Wednesday, September 21, 2022
11:40 AM – 12:00 PM
Wednesday, September 21, 2022
1:00 PM – 1:15 PM
Wednesday, September 21, 2022
2:35 PM – 3:25 PM
Wednesday, September 21, 2022
2:35 PM – 2:40 PM
Wednesday, September 21, 2022
3:10 PM – 3:25 PM
Thursday, September 22, 2022
9:00 AM – 10:10 AM
Thursday, September 22, 2022
9:00 AM – 9:05 AM
Thursday, September 22, 2022
9:45 AM – 10:10 AM
Thursday, September 22, 2022
11:30 AM – 12:35 PM
Thursday, September 22, 2022
11:30 AM – 11:35 AM
Thursday, September 22, 2022
12:15 PM – 12:35 PM
Thursday, September 22, 2022
1:55 PM – 3:20 PM
Thursday, September 22, 2022
1:55 PM – 2:00 PM
Thursday, September 22, 2022
3:00 PM – 3:20 PM